APSR2026-815

Yes
Late-Breaking
Submitted
Poster Presentation
YIA02-001
AP04-017
P92
https://storage.unitedwebnetwork.com/files/1285/1221031-46903-APSR2026-815_439776.pptx
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221031-46904-APSR2026-815_439777.pdf
Format: PDF Only
11. Critical Care Medicine
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Qian Cui * Tianjin Medical University of General Hospital Department of Respiratory Medicine tianjin China
Zhe Chen - Tianjin Medical University of General Hospital Department of Respiratory Medicine tianjin China
Lina Zhao - Tianjin Medical University of General Hospital Department of Critical Care Medicine tianjin China
Hanjun Pei - The First Affiliated Hospital of Baotou Medical College Department of Cardiology baotou China
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Qian
Cui
cqdr0922@163.com
+8618504720922
31-40
China
Original Research
SDHD deficiency drives Sepsis-Associated ARDS through Succinate/HIF-1α-Mediated mitochondrial metabolic reprogramming
Maximum 25 words
Abstract Content
Sepsis-associated acute respiratory distress syndrome (SA-ARDS) has high mortality with no targeted therapies. Mounting evidence suggests lactate accumulation disrupts mitochondrial function, creating a vicious cycle that exacerbates lung injury. While both lactate dysmetabolism and mitochondrial dysfunction are implicated in SA-ARDS progression, the central molecule coordinating this crosstalk remains unknown. This study aimed to identify the key regulator linking lactate-driven mitochondrial impairment to SA-ARDS pathogenesis and dissect its mechanism via the succinate/hypoxia-inducible factor-1α (HIF-1α) axis.
Bioinformatics analysis intersected lactate metabolism, mitochondrial function and SA-ARDS gene sets to screen SDHD as the core target.In vitro, A549 cells were subjected to hypoxia/reoxygenation (H/R) and divided into control, H/R, si-SDHD+H/R, si-SDHD+H/R+α-KG groups, with detection of cell viability, mitochondrial function and protein expression. In vivo, mouse cecal ligation and puncture (CLP) models were divided into sham, CLP, CLP+DMM, CLP+DMM+α-KG groups, to examine lung injury, protein expression and HIF-1α localization.
H/R significantly downregulated SDHD in A549 cells (P< 0.05). SDHD knockdown aggravated H/R-induced reduction of cell viability and mitochondrial dysfunction, and upregulated HIF-1α (P< 0.05), while α-KG intervention reversed these pathological phenotypes (P < 0.05). In CLP-induced SA-ARDS mice, SDHD in lung tissue decreased over time (P< 0.05). DMM further exacerbated CLP-induced lung tissue pathological injury and activated HIF-1α expression (P< 0.05), and immunofluorescence confirmed that HIF-1α was specifically activated in pulmonary macrophages and vascular endothelial cells (P< 0.05). α-KG treatment attenuated DMM-aggravated lung injury and inhibited the abnormal activation of HIF-1α in lung tissue (P< 0.05).
SDHD is a core target mediating SA-ARDS lung injury. Its deficiency or dysfunction exacerbates SA-ARDS by inducing mitochondrial dysfunction and succinate accumulation to stabilize HIF-1α in pulmonary macrophages and endothelial cells. α-KG exerts a protective effect by targeting the succinate/HIF-1α axis, providing a novel molecular target for precise SA-ARDS treatment.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Sepsis-associated acute respiratory distress syndrome, SDHD, succinate/HIF-1α axis, mitochondrial dysfunction, α-ketoglutarate
maximum 3 keywords and no abbreviations, separated by commas
No competing financial interests exist.
313